Thermo Scientific™

Remel™ Wellcolex™ E. coli O157

Número de catálogo: R30959501
Thermo Scientific™

Remel™ Wellcolex™ E. coli O157

Número de catálogo: R30959501
Wellcolex™ E. coli O157 es una prueba de aglutinación en látex rápida para la identificación provisional de aislados de Escherichia coli O157 en medios de laboratorio. La prueba de látex rápida Wellcolex* E. coli O157 se ha clasificado como altamente compleja en virtud de la Ley de mejora de laboratorios clínicos (CLIA88: código del sistema de pruebas 40262; código de análisis 1604).
 
Número de catálogo
R30959501
Formato
Each
Cantidad
Kit para 50 pruebas
Precio (CLP)
Especificaciones completas
DescripciónWellcolex E. coli O157
Analitos detectablesAislados de E. coli O157
TipoKit de pruebas de E. coli
CantidadKit para 50 pruebas
Unit SizeEach
Mostrando 1 de 1
Número de catálogoEspecificacionesFormatoCantidadPrecio (CLP)
R30959501Especificaciones completas
EachKit para 50 pruebasContáctenos ›
DescripciónWellcolex E. coli O157
Analitos detectablesAislados de E. coli O157
TipoKit de pruebas de E. coli
CantidadKit para 50 pruebas
Unit SizeEach
Mostrando 1 de 1

Verocytotoxin-producing E. coli O157 are an important cause of diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome3,4. The pathogenicity of this organism is due to the expression of verocytotoxin (VT1 and/or VT2)5-7. Enteritis due to other serotypes is not unusual but in contrast to the majority of isolates, most E. coli O157:H7 do not ferment sorbitol and this has been used as a differential feature for laboratory identification. Testing suspect colonies with Wellcolex* E. coli O157 helps determine whether the isolate belongs to the O157 serogroup.

The Wellcolex* E. coli O157 Rapid Latex Test is categorised as highly complex under the Clinical Laboratory Improvement Act (CLIA88 : Test System Code 40262; Analyte Code 1604).

  • Ready-to-use: Color coded latex and control reagents
  • Rapid: Results within 30 seconds.
  • Easy-to-interpret: Visible agglutination
  • Less sample required

The Wellcolex* E. coli O157 Test Reagent consists of a buffered suspension of red polystyrene latex particles coated with rabbit IgG antibodies specific for E. coli O157 and 0.05% Bronidox® as preservative. When a drop of the reagent is mixed on a card with a suspension of E. coli O157 organisms, rapid agglutination occurs through the interaction of specific IgG and O157 lipopolysaccharide antigen.

Some faecal coliforms can cause non-specific aggregation of latex particles, particularly when grown on sugar containing media such as MacConkey. Therefore a control latex is provided to assist with the identification of non-specific reactions. The control latex consists of a buffered suspension of red polystyrene latex particles coated with non-immune rabbit IgG and 0.05% Bronidox® as preservative.

The kit is also supplied with Positive and Negative controls. The positive control contains a dilute suspension of heat killed E. coli O157 antigens and 0.05% Bronidox® preservative. The negative control contains a dilute suspension of heat killed E. coli O106 antigens and 0.05% Bronidox® preservative.

Not all products are available for sale in all territories. Please inquire.

Remel™ and Oxoid™ products are now part of the Thermo Scientific brand.

  1. March, S.B. and Ratnam, S. (1986). Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. Journal of Clinical Microbiology, 23:869-872.
  2. Gray, L.D. (1995). Manual of Clinical Microbiology, 6th Ed., edited by Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C and Yolken, R.H. American Society for Microbiology, Washington, D.C. Pages 450-456.
  3. Tarr, P.I. (1995). Escherichia coli O157:H7: Clinical, diagnostic and epidemiological aspects of human infection. Clinical Infectious Diseases, 20:1‑
  4. Wells, J.G., Davis, B.R., et al. (1983). Laboratory investigation of hemorrhagic colitis outbreaks associated with rare Escherichia coli serotype. Journal of Clinical Microbiology, 18:512-520.
  5. Ratnam, S., March, S.B., et al. (1988). Characterization of Escherichia coli serotype O157:H7. Journal of Clinical Microbiology, 26:2006-2012.
  6. Willshaw, G.A., Scotland, S.M., et al. (1992). Properties of Verocytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. Journal of Infectious Diseases, 166:797‑
  7. Thielman, N.M. (1994). Enteric Escherichia coli infections. Current Opinion in Infectious Diseases, 7:582-591.

Figuras

Documentos y descargas

Certificados

    Preguntas frecuentes

    Citas y referencias

    Search citations by name, author, journal title or abstract text